I am a
Home I AM A Search Login

Papers of the Week

2021 Jun 30

Croat Med J



Remifentanil target-controlled infusion with intranasal dexmedetomidine for vitreoretinal procedures: a randomized controlled trial.


Potočnik I, Andjelkovič-Juvan L, Hostnik A, Markovič-Božič J
Croat Med J. 2021 Jun 30; 62(3):233-240.
PMID: 34212560.


To evaluate the consumption of remifentanil (as a primary end-point), analgesia, sedation, hemodynamics, respiratory effects, and surgeon and patient satisfaction (as a secondary end-point) with dexmedetomidine sedation compared with those of remifentanil sedation in patients undergoing vitreoretinal surgery.